Indication
Varicella Zoster Virus Infection
3 clinical trials
3 products
Product
MG1111Clinical trial
An Open-label, Bridging Study to Assess the Safety and Immunogenicity of BARYCELA Inj. (Live Attenuated Varicella Vaccine for Injection) in Healthy Vietnamese Children Aged Between 12 Months to 12 YearsStatus: Not yet recruiting, Estimated PCD: 2023-04-01
Clinical trial
A PhaseⅠ, Randomized, Observer-blinded, Active Comparator, First-in-human Clinical Trial to Evaluate Safety and Tolerability of Herpes Zoster Vaccine EuHZV in Healthy Adults Aged 50 to 69 YearsStatus: Not yet recruiting, Estimated PCD: 2025-05-01
Product
EuHZVProduct
ShingrixClinical trial
VZV-specific Tissue Resident Memory T-cells After Shingrix VaccinationStatus: Recruiting, Estimated PCD: 2025-02-01